Equities

N4 Pharma PLC

N4 Pharma PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.70
  • Today's Change0.05 / 7.69%
  • Shares traded5.78k
  • 1 Year change-9.68%
  • Beta-1.1412
Data delayed at least 20 minutes, as of Nov 22 2024 16:05 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The one analyst offering a 12 month price target expects N4 Pharma PLC share price to rise to 12.00 in the next year from the last price of 0.65.
High1,746.2%12.00
Med1,746.2%12.00
Low1,746.2%12.00

Earnings history & estimates in GBX

N4 Pharma PLC reported annual 2019 losses of -0.87 per share on Feb 25, 2020.
Average growth rate+33.08%
More ▼

Revenue history & estimates in GBP

N4 Pharma Plc did not report revenues for the full year 2019. However, during the prior year the company reported revenues of 73.00k.
Average growth rate-100.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.